Mono- and disaccharides for the treatment of nitric oxide related disorders
US6699846B2 · kind B2 · utility
24Cited by
8References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2001 |
| Grant date | Mar 2, 2004 |
| Priority date | — |
| Expiry date | May 12, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating diseases or conditions modulated or ameliorated by nitric oxide, particularly ischemia and reperfusion injury, are provided, using glycolipids structurally related to monophosphoryl lipid A but with notable reduction in proinflammatory and pyrogenic activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.